| Issue |
Section |
Title |
File |
| Vol 31, No 7 (2020) |
Articles |
BIRTH DEFECTS: THE ROLE OF P-GLYCOPROTEIN |
|
| Vol 32, No 1 (2021) |
Articles |
Analysis of the efficiency and safety of using the slow-release calcium channel blocker nifedipine as a tocolytic drug in pregnant women with preterm labor |
|
| Vol 32, No 2 (2021) |
Articles |
Current approaches to detecting, evaluating, and predicting congenital malformations |
|
| Vol 32, No 8 (2021) |
Articles |
Efficacy and safety of hexaprenaline in pregnant women at risk of premature birth: the effect of polymorphism of the ADRB2 gene |
|
| Vol 32, No 9 (2021) |
Articles |
TOCOLYTIC THERAPY WITH HEXOPRENALINE IN PREGNANT WOMEN AT RISK FOR PREMATURE BIRTH. THE IMPACT OF ADRB2 GENE POLYMORPHISM ON TOCOLYSIS |
|
| Vol 33, No 4 (2022) |
Articles |
Risk for folate-dependent congenital malformations upon preconception exposure to medicines: the impact of ABCB1 gene polymorphism |
|
| Vol 33, No 3 (2022) |
Articles |
FOLATE-DEPENDENT CONGENITAL MALFORMATIONS AND ABCB1 GENE POLYMORPHISM |
|
| Vol 26, No 10 (2015) |
Articles |
THERAPEUTIC EQUIVALENCE, BIOEQUIVALENCE AND INTERCHANGEABILITY OF MEDICINAL PRODUCTS |
|
| Vol 26, No 8 (2015) |
Articles |
WORLD EXPERIENCE IN THE ASSESSMENT OF THE INTERCHANGEABILITY OF PRODUCTS FOR MEDICAL USE |
|
| Vol 28, No 8 (2017) |
Articles |
RISK FACTORS OF PREMATURE BIRTH |
|
| Vol 28, No 10 (2017) |
Articles |
TOCOLYTIC THERAPY WITH β2-ADRENOSTIMULANTS IN WOMEN WITH PREMATURE BIRTH |
|
| Vol 35, No 5 (2024) |
From Practice |
Efficacy of metformin and sibutramine therapy in patients with infertility associated with metabolic syndrome |
|
| Vol 36, No 4 (2025) |
From Practice |
The influence of ABCB1 gene polymorphisms on the development of threatened preterm labor in pregnant women of the Russian population |
|
